NCT04845386

: A Comparison of Neuromuscular Transmission in the Muscles During General Anesthesia

Name: Clinical Trial NCT04845386
Creator: University of Warmia and Mazury in Olsztyn
Keywords: Neuromuscular Blockade, TOF Cuff on arm, device, clinical trial, Poland

A Comparison of Neuromuscular Transmission in the Arm and Hand Muscles With Alternative Muscles Such as the Lower Leg Muscles and the Corrugator Supercilii During General Anesthesia

University of Warmia and Mazury in Olsztyn·ClinicalTrials.gov·device·Device trialEnrolling by invitation

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Neuromuscular Blockade
Drug/Device/Intervention: TOF Cuff on arm
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: University of Warmia and Mazury in Olsztyn
Location: Olsztyn, Poland

Timeline & enrollment

Phase: N/A
Start date: Mar 25, 2021
End date: Jun 25, 2021
Enrollment: 130 participants

Primary outcome

Onset time,Total recovery time of neuromuscular block

Summary

The investigators want to compare new muscle relaxation monitoring, TOF-Cuff and TOF-Scan, during general anesthesia. Standard monitoring is using thumb, however it can't be use on every patient. Alternative can be eyebrow muscle or foot muscle.  There is only few old study that compares this muscle and used mivacurium. The study aims to compare TOF-Cuff and TOF-Scan with different sensor and use mivacurium.

ICD-10 classifications

Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents]Other neuromuscular dysfunction of bladderNeuromuscular dysfunction of bladder, unspecifiedNeuromuscular scoliosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04845386
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT04845386 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Warmia and Mazury in Olsztyn and is currently Enrolling by invitation. The study focuses on Neuromuscular Blockade. Target enrollment is 130 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.